As Canada prepares for the fall return of Parliament, a major policy question is emerging across industries: what is the country’s economic strategy for the next decade, and what role should health play in it?

After attending the Canadian Chamber of Commerce’s B7 summit in May, BD-Canada posed the question: what happens when we shift our view of health as a strategic investment instead of a spending item? This episode of From the Burgundy Chairs reframes medical technologies not as cost centres, but as strategic investments -vital tools to strengthen Canada’s economic resilience, create high-value jobs, and fuel innovation.

In our latest podcast, we explore how a stronger, more integrated MedTech ecosystem can support national priorities from workforce productivity to global competitiveness, and why now is the moment to embed health innovation into Canada’s economic planning.

—

Robyn Saccon, Vice President of Public Affairs, BD-Canada

Robyn Saccon is Vice President of Public Affairs at BD-Canada, a global medical technology company that advances health care by improving discovery, diagnostics and delivery of care. Robyn has led BD’s efforts to strengthen system partnerships and shape health policy through evidence-based advocacy.

Rob Pankhurst, Vice President (West), Medtech Canada

Rob Pankhurst is the Vice President (West) of Medtech Canada, the national association representing the medical technology industry. Rob brings deep public and private sector experience, and is a vocal advocate for aligning government priorities with industry innovation.